2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Atypical Ductal Hyperplasia in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, H | 1 |
| Saulnier, R | 1 |
| Patryzkat, A | 1 |
| Rahimi, N | 1 |
| Raptis, L | 1 |
| Rossiter, J | 1 |
| Tremblay, E | 1 |
| Elliott, B | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Topics: Animals; Carcinoma, Intraductal, Noninfiltrating; Cell Adhesion; Cell Survival; Cells, Cultured; Chr | 2000 |